Stockscreener 앱 받기
0.00
100.00%
-31.49
시간 외 거래:
31.48
31.48
+
Catalyst Pharmaceuticals Inc 주식(CPRX)의 최신 뉴스
Catalyst Pharmaceuticals stock leaves Nasdaq after USD 4.1 billion deal - AD HOC NEWS
Catalyst Pharmaceuticals (CPRX) Trades Flat at $31.49, Holding Inside a Well-Defined RangeWatchlist Stock Ideas - careplusvn.com
Catalyst Pharmaceutical Inc. (CPRX) Revenue 2025: $589.0M, up 19.8% - Stock Titan
Catalyst (CPRX) Quarter in Focus: Reported EPS Tops Expectations for the Current Session; Investor Response: Shares Show Little Net ChangeEarnings Seasonality - vinanet.vn
Catalyst Pharmaceuticals (CPRX) Holds Flat at $31.49 as Traders Eye $33.06 ResistanceLinear Regression - vinanet.vn
Chuck Royce's Second Quarter 2026 13F: Catalyst Pharmaceuticals Reduction Leads Portfolio Shifts - GuruFocus
Is Biohaven (BHVN)’s Latest Regeneron Pharmaceuticals (REGN) Deal a Major Catalyst for its Pipeline? - Yahoo Finance
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Navigating Stability with a 24.5% Return on Equity - DirectorsTalk Interviews
How Catalyst Pharmaceuticals Inc. (CPRX) Affects Rotational Strategy Timing - Stock Traders Daily
Catalyst Pharmaceuticals Inc (CPRX) Stock News Today - TradingKey
Catalyst Pharmaceuticals Inc (CPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rigel Pharmaceuticals: A Four-Drug Company With A Clinical Catalyst Ahead (NASDAQ:RIGL) - Seeking Alpha
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Stable Outlook Amidst Consistent Valuation - DirectorsTalk Interviews
Catalyst Pharmaceuticals (CPRX) Holds Steady at $31.49: Key Support and Resistance Levels in FocusMarket Leader Picks - vinanet.vn
Catalyst Pharmaceuticals, Inc. Revenue Breakdown – LS:A0LCUL - TradingView
Catalyst Pharmaceuticals Inc (CPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CPRX|Catalyst Pharmaceuticals Inc|Price:31.490| - TradingKey
Catalyst Pharmaceuticals Inc (CPRX) Cash Flow - TradingKey
TradingKey - TradingKey
CATALYST PHARMACEUTICALS, INC. SEC Filing (Jul 24, 2026) - Stock Titan
Catalyst Pharmaceuticals, Inc. $CPRX Stock Holdings Raised by Globeflex Capital L P - MarketBeat
Catalyst Pharmaceuticals | 8-K/A: Current report (Amendment) - Moomoo
Catalyst Pharmaceuticals stock steadies as investors weigh latest earnings momentum - AD HOC NEWS
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) leaves Nasdaq after cash reserves reduce deal multiple - TechStock²
Catalyst Pharmaceuticals (NASDAQ:CPRX) departs Nasdaq as merger spread narrows to one cent - TechStock²
Catalyst Pharmaceuticals CLO Brian Elsbernd Sells 242,501 Shares Amid Angelini Pharma Acquisition Completion - Kalkine Media
Catalyst Pharmaceuticals (CPRX) director’s RSUs and options cashed out in merger - Stock Titan
Catalyst Pharmaceuticals (NASDAQ: CPRX) HR chief equity cashed out at $31.50 - Stock Titan
Catalyst Pharmaceuticals (NASDAQ: CPRX) director equity converted to cash at $31.50 - Stock Titan
Angelini deal converts CATALYST PHARMACEUTICALS (NASDAQ: CPRX) officer equity to cash - Stock Titan
Catalyst Pharmaceuticals (CPRX) CCO exits equity in Angelini merger - Stock Titan
Catalyst Pharmaceuticals (CPRX) CEO equity converted to cash at $31.50 merger price - Stock Titan
Catalyst Pharmaceuticals (CPRX) CMO equity awards canceled for cash in Angelini merger - Stock Titan
Catalyst Pharmaceuticals (CPRX) CFO equity cancelled for cash in acquisition - Stock Titan
Catalyst Pharmaceuticals (CPRX) director’s RSUs and options cancelled in merger - Stock Titan
CATALYST PHARMACEUTICALS, INC. SEC Filing (Jul 17, 2026) - Stock Titan
CATALYST PHARMACEUTICALS, INC. SEC Filing (Jul 17, 2026) | CPRX EFFECT - Stock Titan
Catalyst Pharmaceuticals, Inc. Files 8-K: Merger Agreement Details, Corporate Information & XBRL Data (2026) - Minichart
Angelini Pharma completes $4.1 billion Catalyst acquisition By Investing.com - Investing.com Australia
Italy’s Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst - 1470 & 100.3 WMBD
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst - Reuters
CATALYST PHARMACEUTICALS, INC. SEC Filing (Jul 15, 2026) - Stock Titan
Catalyst Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Angelini Pharma completes $4.1 billion Catalyst acquisition - Investing.com
Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals - NTB Kommunikasjon
Angelini wraps $4.1 billion buyout of Catalyst Pharmaceuticals (NASDAQ:CPRX) at 9x projected 2026 EBITDA - TechStock²
Nasdaq moves to delist Catalyst Pharmaceuticals (Nasdaq: CPRX) common stock - Stock Titan
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Shows Strong Growth and a High-Quality Technical Breakout Setup - ChartMill
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P 1000 - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P 600 Health Care - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P Composite 1500 - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P 600 - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P TMI Index - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P Global BMI Index - marketscreener.com
Angelini Pharma S.p.a. completed the acquisition of Catalyst Pharmaceuticals, Inc. from a group of shareholders. - marketscreener.com
Catalyst Pharmaceuticals (CPRX) Could Be 60% Undervalued As Merger Approval Reshapes The Board - Sahm
Catalyst Pharmaceuticals (CPRX) Holds Steady Near $31.50 Amid Sector ConsolidationWatchlist Stock Ideas - dars.gov.et
Catalyst Pharmaceuticals (CPRX) Holds Steady Near Support as Consolidation PersistsBearish Pattern Stocks - Bölüm Sonu Canavarı
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX): A Textbook GARP Stock Delivering Affordable Growth - ChartMill
Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger - Yahoo Finance
3.06%
2.55%
자본화:
|
볼륨(24시간):